Description
Release form
Capsules.
Pharmacological action of
Hepatoprotective efficacy of Hepaphor is due to the peculiarity of its structure, which provides a mutually potentiating effect of all its constituent components – milk thistle extract and probiotic component, containing microcolonies of bifidobacteria and lactobacilli sorbed on silicon dioxide.
Dry spotted milk thistle extract:
Has a stabilizing effect on the liver cell membrane.
Inhibits the processes of cytolysis and the penetration of toxins into liver cells.
Stimulates the synthesis of proteins and enzymes in hepatocytes.
Prevents the development of cholestasis.
Probiotic component, containing microcolonies of sorbed bifidobacteria and lactobacilli: Reduces the toxic load on the liver.
Participates in the metabolism of proteins, fats and carbohydrates, providing the formation of amino acids, vitamins, organic and short chain fatty acids, improving trophic tissue and liver function.
Transforms exo- and endotoxins, turning them into non-toxic compounds that are excreted from the body.
Restores the process of evacuation of bile and prevents the formation of gallstones.
Creates optimal conditions for the rapid restoration of intestinal normoflora and its protective functions
Indications
The drug is used by adults of all age groups in complex therapy for the treatment of:
Toxic liver damage (including medicinal).
Acute viral and chronic hepatitis, including medicinal ones, including those developed during the use of anti-tuberculosis drugs, and to restore intestinal normal flora.
Chronic hepatitis of various etiologies, including those with dysfunction of the biliary tract.
Cirrhosis of the liver (as part of complex therapy).
Condition after hepatitis.
Acute viral hepatitis.
Cirrhosis of the liver.
A prophylactic drug is used for chronic intoxication (including professional), long-term use of drugs and alcohol.
Contraindications
Individual intolerance.
Special instructions
It is recommended that you consult a specialist before use.
Composition
active ingredients:
milk thistle dry extract 0.1 g
bifidobacteria bifidum, sorbed on silicon dioxide colloid no less than 50 million (5 107) CFU
lactobacilli no less than enzyme 50 million (5 107) CFU
excipients: lactulose – up to 0.2 g of silicon colloidal dioxide – 0.0006 g
Dosage and administration of
For the treatment of acute viral hepatitis: 1 capsule 3 times a day, the course of treatment is 15 days.
For the treatment of other diseases: 2 capsules 3 times a day, the course of treatment is 14-30 days.
For prevention: 1-2 capsules 3 times a day, the course of treatment is 14-30 days, if necessary, the course is repeated after 1-3 months.
Storage conditions
Store at 2 to 10 ° C. Transportation is allowed at temperatures above 25 ° C for no more than 10 days.
Active ingredient
Milk thistle dry dry, bifidobacteria bifidum, lactobacillus fermentum
Terms of delivery from pharmacies
Over-the-counter
Dosage form
capsule
